Company / Free Cash Flow per Share
Sunshine Biopharma Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$5.50
FY2025
5-year range
-$632.13 / -$0.24
FY2021-FY2025
Trend
+99.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-632.13 in FY2024 to $-0.00 in FY2017.
Based on SEC 10-K filings.
-5.50 in FY2025.
Declined from $-0.24 to $-5.50 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share increased 99.1% year-over-year.
- Peak free cash flow per share was recorded in FY2017.
- Lowest free cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.50 | +99.1% |
| FY2024 | -$632.13 | -262231.7% |
| FY2023 | -$0.24 | +65.9% |
| FY2022 | -$0.71 | -85.7% |
| FY2021 | -$0.38 | -2603.6% |
| FY2020 | -$0.01 | +88.7% |
| FY2019 | -$0.12 | -942.1% |
| FY2018 | -$0.01 | -2785.7% |
| FY2017 | -$0.00 | +90.6% |
| FY2016 | -$0.00 | +39.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026